Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional MMR Vaccine vs Candida Antigen vs Podophyllin for Genital Warts
NCT03853785Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, open-label trial of measles, mumps, and rubella vaccine in condylomata acuminata (3 arms), sponsored by Assiut University. Primary endpoint: Cure rate at 45 days. Status: unknown.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
condylomata acuminata
Beyond the preview
Go deeper on NCT03853785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03853785.